ACT Dad Interview: ACT for Fathers of Children With Special Needs

NCT07591636 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-05-18

No results posted yet for this study

Summary

The goal of this qualitative study is to develop a therapy protocol for fathers of children with special needs in Hong Kong. The therapy is called Acceptance and Commitment Therapy (ACT), which helps people cope with difficult emotions by building psychological flexibility - the ability to accept and adjust to hard situations. The main questions it aims to answer are:

1. What are the experiences and needs of fathers raising children with special needs?
2. What content and format of an ACT programme would be most helpful for these fathers?

Researchers will conduct focus group interviews with two groups of participants: fathers raising children with special needs and social workers who work with these families. The interviews will take about 60 to 90 minutes each.

Participants will:

1. Take part in a recorded focus group interview
2. Share their experiences, challenges, and views on what an ACT program should include

The findings will be used to develop a protocol for an ACT programme to improve the mental health of fathers raising children with special needs.

Conditions

  • Caregiver Mental Health
  • Parenting Stress
  • Developmental Disabilities
  • Special Needs Children
  • FATHER

Interventions

OTHER

Semi-structured Focus Group Interview

Participants will take part in a 60 to 90-minute, video-recorded, semi-structured focus group interview conducted in Cantonese.

Sponsors & Collaborators

  • The Hong Kong Polytechnic University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2027-05-01
Completion
2027-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07591636 on ClinicalTrials.gov